Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Treatment of therapy-induced preleukemic syndrome
1984
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor
2008
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Caspase Inhibition Selectively Reduces the Apoptotic Component of Oxygen-Glucose Deprivation-Induced Cortical Neuronal Cell Death
1997
Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas
1988
Testicular Germ-Cell Cancer
1997 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Acute lymphoblastic leukaemia
2008
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia.
1994 StandoutNobel
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
2004
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
The chromosomal analysis of human solid tumors a triple challenge
1989
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
2009 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001
2002
Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell Tumors
1990
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
1995
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Genetic instabilities in human cancers
1998 StandoutNature
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
A genetic model for colorectal tumorigenesis
1990 Standout
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
2002
Apoptotic detection methods — from morphology to gene
2003
Telomere states and cell fates
2000 StandoutNatureNobel
Immunogenic cell death in cancer and infectious disease
2016 Standout
Characteristic chromosomal imbalances in 18 near-diploid colorectal tumors
1987
Tumor suppressor genes
1991 Standout
Antibody therapy of cancer
2012 Standout
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Hereditary Colorectal Cancer
2003 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Long‐term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single‐center experience
2005
Self-eating and self-killing: crosstalk between autophagy and apoptosis
2007 Standout
Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens.
1994 StandoutNobel
Applying the discovery of the Philadelphia chromosome
2007
Autophagy in cell death: an innocent convict?
2005 Standout
Autophagy: process and function
2007 Standout
Genetic Alterations during Colorectal-Tumor Development
1988 Standout
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Philadelphia chromosome‐positive mixed phenotype acute leukemia in the imatinib era
2014
Specific chromosomal abnormalities in malignant human gliomas.
1988
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
1992 StandoutScience
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase
2000 Standout
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients
2007
Pathogenetic significance of ?pure? monosomy 7 in myeloproliferative disorders. analysis of 14 cases
1982
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.
1999
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinoma
2012
Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation
1998
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
1989 Standout
Concerted Nonsyntenic Allelic Loss in Human Colorectal Carcinoma
1988 Science
Evidence for the Involvement of GM-CSF and FMS in the Deletion (5q) in Myeloid Disorders
1986 Science
Spermidine in health and disease
2018 StandoutScience
Next Generation of Immunotherapy for Melanoma
2008
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
1986
Cancer treatment and survivorship statistics, 2016
2016 Standout
Chromosomal Abnormalities in Leukemia and Lymphoma: Clinical and Biological Significance
1986
Ischemic Cell Death in Brain Neurons
1999 Standout
Clonal Analysis of Human Colorectal Tumors
1987 Science
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.
1987 StandoutNobel
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
1997 StandoutScience
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteases
1998
Pivotal Role of the Cell Death Factor BNIP3 in Ceramide-Induced Autophagic Cell Death in Malignant Glioma Cells
2004
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Therapy‐induced preleukaemia in patients treated for Hodgkin's lymphoma: clinical and therapeutic relevance of sequential chromosome banding studies
1984
Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B Inhibitors
2005
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients
1984
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
2008
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 StandoutScience
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience
Works of Jin Takeuchi being referenced
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
2012
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia
2013
Myeloblastoma formation in acute myeloid leukemia
1992
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study
2010
Morphological diagnoses of the Japan Adult Leukemia Study Group acute myeloid leukemia protocols: Central review
2001
Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells.
1995
Possible specific chromosome changes in large bowel cancer
1983
Cytogenetic studies in adult acute leukemias
1981
Chromosomes and causation of human cancer and leukemia. L. Cytogenetics of leukemias complicating other diseases
1982
High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group
2005
Lower Dose of Imatinib Provides Outcomes Similar to the Standard Dose Imatinib in Japanese Patients with Early Chronic-Phase CML: The Interim Analyses of JALSG CML202 Study.
2007